Research knowledge hub, [Sep 2, 2025 at 7:18:34 AM]:

…🔍 Description:

Vilon is a Khavinson peptide bioregulator derived from the thymus and is closely related to Thymalin. It consists of two amino acids: lysine and glutamic acid. Vilon has been widely studied for its immune-modulating and anti-inflammatory properties, promoting immune health by enhancing T-cell differentiation and phagocytosis. It has shown promise in applications for a wide range of conditions, including those affecting the immune system, digestive system, and skin health. Vilon has also demonstrated geroprotective effects by extending lifespan in animal models.

🎯 Target System(s):

– Immune system

– Digestive system

– Skin health

💪 Health Benefits:

– Immune System Support: Vilon enhances the immune system by stimulating the production of T-lymphocytes and phagocytic activity, improving the body’s ability to fight off infections and diseases.

– Anti-Inflammatory: It has potent anti-inflammatory properties that can aid in the treatment of chronic inflammatory conditions, helping to balance immune responses and reduce tissue inflammation.

– Skin Health: Vilon, when applied topically, helps reduce skin irritation, inflammation, and promote healing in conditions like eczema, psoriasis, and wound healing.

– Geroprotective Effects: Studies show that Vilon extends lifespan, improves endurance, and enhances overall physical health by supporting DNA stabilization and preventing age-related neoplasms.

💉 Dosing/Administration:

– Capsule Dosing: Vilon is available in 10-20 mg capsules with a recommended dosage of 1 capsule daily for 20-30 days. This cycle can be repeated multiple times per year based on health conditions and therapeutic goals.

– Injectable Dosing: In clinical or research settings, Vilon is administered subcutaneously at 0.1-0.2 mg daily for 10-20 days for enhanced immune support and therapeutic benefits.

⚠️ Side Effects and Safety:

– Vilon is generally well-tolerated, with minimal side effects. Mild symptoms may include gastrointestinal discomfort or localized irritation at injection sites. No severe adverse effects have been documented, making it safe for prolonged use.

– Note: Vilon is intended solely for research purposes and is not approved for human consumption or therapeutic use outside of controlled studies.

📚 References:

Research knowledge hub, [Sep 2, 2025 at 7:18:42 AM]:

https://pubmed.ncbi.nlm.nih.gov/15105581/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8999041/